Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,065 DKK | +1.98% | +3.10% | -4.18% |
04:14pm | Genmab CEO Says Western Firms Should Tap Into China's 'Impressive Innovation' | MT |
02:28pm | Bolt Biotherapeutics Stops Development of Trastuzumab Imbotolimod, Cuts Workforce by 50% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.18% | 18.97B | |
+7.63% | 111B | |
+11.42% | 106B | |
-12.38% | 22.24B | |
+0.44% | 21.25B | |
-37.85% | 18.52B | |
-8.78% | 16.81B | |
+38.47% | 12.54B | |
-24.36% | 8.09B | |
+312.33% | 7.99B |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Transcript : Genmab A/S Presents at Goldman Sachs 39th Annual Global Healthcare Conference, Jun-12-2018 04